Saxenda has been available as an FDA approved medication for use in adults since 2014 as a once daily injectable medication
ranking highly in terms of the percentage of the population with obesityin America, it is over 36 percent or around 119 million peoplethe drug has appeared much-needed in a time of processed foods and over-indulgence
This dual-action approach provides a novel pathway for managing diabetes, diverging from the singular GLP-1 receptor agonism seen in Semaglutide based treatments
Also seek medical advice if you develop a lump in your neck, hoarseness, or difficulty swallowing, as these could indicate thyroid issues
Obesity is primarily an issue of our brain biology, and the way its processing info about the environment we live in, says Randy Seeley, a University of Michigan researcher focused on obesity treatments, who also consults with Novo Nordisk